IL-8 polymorphisms (-251T/A, -1633T/C) and their effects on COVID-19 clinical outcomes: An observational study.

Publication date: Jun 26, 2025

COVID-19 presents with a wide spectrum of clinical outcomes, ranging from asymptomatic infection to critical illness. The cytokine storm is a hallmark of severe COVID-19 and is associated with elevated levels of pro-inflammatory cytokines, often observed in severe cases. Genetic polymorphisms in the IL-8 gene may influence individual responses to SARS-CoV-2 infection and the severity of the disease. A case-control study was conducted involving 200 COVID-19 patients and 201 healthy controls. Two IL-8 gene polymorphisms, -251T/A and +1633T/C, were genotyped using the PCR-RFLP (Polymerase chain reaction-restriction fragment length polymorphism) technique. The IL-8 -251TA genotype and -251A allele were significantly associated with COVID-19 patients (P=0. 02, OR=2. 31; P=0. 03, OR=1. 38). The AT haplotype (-251A/+1633C) showed a non-significant trend toward increased risk for COVID-19 (P=0. 11, OR=2. 24). The IL-8 +1633TT genotype was associated with impaired platelet counts among COVID-19 patients (P=0. 05, OR=2. 42). The IL-8 -251TA genotype was significantly associated with all stages of COVID-19 severity-critical (P=0. 05, OR=8. 15), severe (P=0. 002, OR=2. 74), moderate (P=0. 008, OR=2. 16), and mild (P=0. 01, OR=2. 89). In contrast, the IL-8 -251AA genotype was significantly associated with the critical stage (P=0. 04, OR=2. 53). A marginally significant association was observed between the IL-8 +1633CT genotype and the severe stage of COVID-19 (P=0. 07, OR=2. 13). Additionally, a borderline significant association was noted between elevated serum creatinine levels and the IL-8 -251AA genotype (P=0. 07, OR=2. 45). In conclusion, the IL-8 -251T/A polymorphism may serve as a potential risk factor for severe disease progression; the +1633TT genotype may be linked to thrombocytopenia and poor clinical outcomes; and the -251AA genotype may be associated with elevated serum creatinine levels and an increased risk of renal dysfunction.

Concepts Keywords
1633t clinical outcomes
Genetic Coronavirus disease of 2019
Healthy CRP
Thrombocytopenia IL-8 Polymorphism
platelet counts
serum creatinine

Semantics

Type Source Name
disease MESH COVID-19
disease MESH asymptomatic infection
disease MESH critical illness
disease MESH cytokine storm
pathway REACTOME SARS-CoV-2 Infection
disease MESH RFLP
drug DRUGBANK Creatinine
disease MESH disease progression
disease MESH thrombocytopenia
pathway KEGG Coronavirus disease

Original Article

(Visited 3 times, 1 visits today)